Author

Louis-Alexandre Fournier

BC Cancer AgencyORCID 0000-0002-4649-1197Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Research Focus:synaptic & neural circuits· 1

Frequent Co-Authors

Alynn Shanks· 1 shared David D. HuntsmaniD· 1 shared Edmund SuiD· 1 shared Forouh KalantariiD· 1 shared Genny Trigo‐Gonzalez· 1 shared James P. WellsiD· 1 shared Joon S. LeeiD· 1 shared Justin White· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alynn Shanks

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancersPeer-reviewedAug 24, 2024

Genome-wide CRISPR screen identifies KEAP1 perturbation as a vulnerability of ARID1A-deficient cells

Louis-Alexandre Fournier, Forouh Kalantari, James P. Wells…·Peter C. Stirling

The paper identifies KEAP1 as a genetic dependency in ARID1A-deficient clear cell ovarian carcinoma cells through a genome-wide CRISPR screen, showing KEAP1 perturbation leads to growth inhibition.

4 citations

humangenetic perturbation / CRISPR

𝕏 PostBluesky